Decision-making about hormone replacement therapy by women in England and Scotland

A. Welton Medical Research Council General Practice Research Framework at the MRC Clinical Trials Unit, London, England

J. Hepworth Department of Psychology, Queen Margaret University College, Edinburgh, Scotland

N. Collins Medical Research Council General Practice Research Framework at the MRC Clinical Trials Unit, London, England

D. Ford Medical Research Council General Practice Research Framework at the MRC Clinical Trials Unit, London, England

C. Knott Medical Research Council General Practice Research Framework at the MRC Clinical Trials Unit, London, England

S. Meredith Medical Research Council General Practice Research Framework at the MRC Clinical Trials Unit, London, England

A. Walgrove Medical Research Council General Practice Research Framework at the MRC Clinical Trials Unit, London, England

H. Wilkes Medical Research Council General Practice Research Framework at the MRC Clinical Trials Unit, London, England

M. Vickers Medical Research Council General Practice Research Framework at the MRC Clinical Trials Unit, London, England

& on behalf of the Women's International Study of long Duration Oestrogen after Menopause (WISDOM) team show all

Abstract

ObjectiveThe aim of this study was to explore women's decision-making about the balance of risks and benefits of taking hormone replacement therapy (HRT) based on the latest evidence from the Women's Health Initiative (WHI) trial of combined HRT.

Methods Women aged 50–69 years, who were eligible for the Women's International Study of long Duration Oestrogen after Menopause (WISDOM) trial, were invited to participate in one of eight focus groups. Participants were asked to discuss their views about taking HRT based on the latest international evidence.

Results and conclusions Eighty-two women participated overall. Qualitative content analysis was applied to the discussion transcripts. Women regarded the decisions they make about taking HRT as highly personal, and, for women currently taking HRT, the overwhelming reason for continuation was perceived improvement in quality of life regardless of either the risks or the benefits in the longer term.

Keywords

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Decision-making about hormone replacement therapy by women in England and Scotland

Information for

Open access

Opportunities

Help and information

Decision-making about hormone replacement therapy by women in England and Scotland

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature